These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6152465)

  • 1. The molecular basis of polypeptide hormone production by medullary thyroid cancer.
    Lips CJ; Steenbergh PH; Höppener JW; Zandberg J; Jansz HS
    Henry Ford Hosp Med J; 1984; 32(4):269-72. PubMed ID: 6152465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of calcitonin measurement for the diagnosis of medullary cancer of the thyroid in a family with multiple endocrine adenoma syndrome of type IIB].
    Pumarino H; Riesco J; Michelsen H; Campino C; Cembal J; Generini G
    Rev Med Chil; 1984 Jul; 112(7):675-80. PubMed ID: 6151224
    [No Abstract]   [Full Text] [Related]  

  • 3. Medullary thyroid cancer in a Wisconsin kindred with Sipple's syndrome: the use of provoked calcitonin testing.
    Witte RS; Starling JR; Warner T; Davis TE
    Wis Med J; 1982 Nov; 81(11):22-5. PubMed ID: 6130656
    [No Abstract]   [Full Text] [Related]  

  • 4. The molecular biology of Laron dwarfism and medullary thyroid cancer.
    Jackson CE; Norum RA
    N Engl J Med; 1989 Oct; 321(15):1039-40. PubMed ID: 2571085
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of medullary thyroid carcinomas.
    Hamoir M; Maisin JP; Warnier P; Ketelslegers JM; Rahier J
    Acta Otorhinolaryngol Belg; 1987; 41(5):782-92. PubMed ID: 2899945
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
    González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
    Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-genetic aspects of medullary thyroid cancer].
    Gar'kavtseva RF; Lisnianskiĭ IE
    Vopr Onkol; 1989; 35(6):663-8. PubMed ID: 2568716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for hereditary medullary cancer in Denmark.
    Emmertsen K
    Henry Ford Hosp Med J; 1984; 32(4):238-43. PubMed ID: 6152458
    [No Abstract]   [Full Text] [Related]  

  • 9. Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis.
    Goodfellow PJ
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):177-85. PubMed ID: 7913024
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial medullary carcinoma of the thyroid: clinical studies in northern New England.
    Noll WW; Maurer LH; Herzberg VL; Beisswenger PJ; Quinn BM; Cate CC; Bassick JP; Clark PA; Colacchio TA
    Henry Ford Hosp Med J; 1984; 32(4):244-5. PubMed ID: 6152459
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous and induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members.
    Tsioupra K; West LF; Davis MB; Parrington JM; Delhanty JD
    Dis Markers; 1988 Jun; 6(2):127-32. PubMed ID: 2456871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening in medullary thyroid carcinoma.
    Calmettes C
    Henry Ford Hosp Med J; 1987; 35(2-3):99-100. PubMed ID: 2891655
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative study of a proposed interstitial del (20p 12.2) in multiple endocrine neoplasia (MEN-II).
    Krizman DB; Pathak S; Samaan NA; Chong JL; Hickey RC
    Anticancer Res; 1986; 6(2):191-4. PubMed ID: 2871802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic disorders involving parathyroid hormone and calcitonin.
    Aurbach GD
    Birth Defects Orig Artic Ser; 1971 May; 7(6):48-54. PubMed ID: 4155962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal instability in medullary carcinoma of the thyroid.
    Samaan NA; Hsu TC; Pathak S; Saad MF; Ordonez NG; Hickey RC
    World J Surg; 1984 Aug; 8(4):487-92. PubMed ID: 6148807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventive thyroidectomy in hereditary medullary thyroid gland carcinoma].
    Görtz G; Kress JH; Schmid KW
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():199-201. PubMed ID: 9101830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A French Canadian family with multiple endocrine neoplasia type 2 syndromes.
    Verdy MB; Cadotte M; Schurch W; Sturtridge WC; Cantin J; Weber AM; Lacroix A; Forster-Gibson C
    Henry Ford Hosp Med J; 1984; 32(4):251-3. PubMed ID: 6152461
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
    Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
    Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple endocrine neoplasia. MEN type IIa and type IIb].
    Miyauchi A; Takai S
    Nihon Rinsho; 1983 Jun; 41(6):1286-91. PubMed ID: 6137577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.